Condition: Sarcoma · Sarcoma, Leiomyo-, Adult · Sarcoma, Synovial, Adult · Sponsor: Royal Marsden NHS Foundation Trust
This is a cohort study aimed at developing a stratified medicine approach for personalised neoadjuvant chemotherapy (NCT) in high-risk soft tissue sarcoma (STS) patients with dedifferentiated liposarcoma (DDLPS), leiomyosarcoma (LMS), synovial sarcoma (SS), vascular sarcomas, malignant peripheral nerve sheath tumour (MPNST) or other subtypes. It comprises of both retrospective and prospective tissue collection from patients advancing directly to surgery (control group) and patients receiving NCT and surgery.
This description comes directly from the study's public registry record.
Stephanie Elston, MSc · 02073528171 · PANTHRS.Trial@rmh.nhs.uk
Thuy-Giang Nguyen, BSc · 02073528171 · PANTHRS.Trial@rmh.nhs.uk
Always discuss trial participation with your own doctor first.
| The Royal Marsden Hospital | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07432932